Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Philip Morris to end Marlboro cigarette sales in UK within a decade

Mon, 26th Jul 2021 12:33

July 26 (Reuters) - Tobacco group Philip Morris
International will stop selling Marlboro cigarettes in
Britain within a decade, its chief executive told https://www.dailymail.co.uk/news/article-9822189/Tobacco-giant-Philip-Morris-stop-selling-cigarettes-Britain-ten-years.html
the Daily Mail, in line with the country's wider ambition to
stamp out smoking by 2030.

"I think in the UK, ten years from now maximum, you can
completely solve the problem of smoking," Chief Executive
Officer Jacek Olczak said in the report, adding that it would
require the help of governments and regulators.

Doing its part, Olczak said the Marlboro brand "will
disappear" from British store shelves along with its other
brands, ending a more than 100-year association with the
country.

Olczak, who has embarked on a more aggressive strategy to
diversify the world's largest tobacco company away from
cigarettes, has previously https://www.telegraph.co.uk/business/2021/07/24/marlboro-maker-calls-cigarette-ban-britain
called on Britain to treat cigarettes like petrol cars and ban
them in 10 years time.

The $153 billion-dollar company sells Marlboro cigarettes
outside the United States, after it split off from parent
company Altria in 2008. Altria sells Marlboro in the U.S.

Earlier this month, Philip Morris launched a 1.05 billion
pound bid for British asthma drug-maker Vectura as part
of its "evolution into a broader healthcare and wellness
company," that will also see it get more than 50% of its revenue
from smoke-free products and at least $1 billion from products
beyond nicotine by 2025.

The deal has received backlash https://www.theguardian.com/business/2021/jul/25/tobacco-firm-philip-morris-calls-for-ban-on-cigarettes-within-decade
from anti-tobacco groups and has spurred a reaction from the
World Health Organization, which called such healthcare
partnerships by Big Tobacco as undermining its progress on
controlling its "deadly products."
(Reporting by Siddharth Cavale in Bengaluru; Editing by Bernard
Orr)

More News
26 Nov 2018 09:05

Vectura Discontinues VR375 As Phase Three Study Misses Endpoints

LONDON (Alliance News) - Respiratory disease-focused pharmaceutical firm Vectura Group PLC said on Monday its phase three study of VR375 in adult and adolescent patients with severe uncontrolled a

Read more
22 Oct 2018 08:59

Vectura Says New Chief Financial Officer Fry Has Started Week Early

LONDON (Alliance News) - Medical devices developer Vectura Group PLC said Monday Paul Fry will become chief financial officer immediately, rather than from Monday next week.Fry succeeds who

Read more
11 Sep 2018 09:40

Vectura Interim Loss Narrows On Higher Revenue And Lower Expenses

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC on Tuesday said its loss narrowed in the first half of 2018 as it reduced operating costs.Pretax loss narrowed to GBP29.9 in a

Read more
11 Sep 2018 08:18

Vectura's solid interims turn focus further forward

(Sharecast News) - Vectura kept guidance for the full year unchanged as the inhaled medicines specialist reported robust revenue and said it has identified pipeline projects with potential annual sales of over $250m.

Read more
10 Sep 2018 12:49

Vectura Launches Flutiform Inhaler In The UK, Europe To Follow

LONDON (Alliance News) - Vectura Group PLC said Monday that it launched its flutiform k-haler, an inhaler to treat asthma, in the UK.The company said it expects further launches across to a

Read more
4 Sep 2018 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 5 September Barratt DevelopmentsFull Year ResultsBreedon GroupHalf Year Year 6

Read more
23 Aug 2018 14:17

Thursday broker round-up

(Sharecast News) - TalkTalk: Barclays upgrades to overweight with a target price of 150p.

Read more
21 Aug 2018 12:31

Vectura concludes two paediatric studies into VR647

(Sharecast News) - Vectura announced the successful conclusion of two paediatric studies to support the potential use of VR647, its wholly-owned drug/device combination asset, on Tuesday.

Read more
21 Aug 2018 09:45

Vectura Group Gets Positive Results From VR647 Phase II Study

LONDON (Alliance News) - Vectura Group PLC said Tuesday that it received positive results form two paediatric studies of its VR647 inhalation system to manage asthma.The two studies, a and

Read more
17 May 2018 10:55

Vectura Group On Track To Achieve Expected Full-Year Revenue

LONDON (Alliance News) - Inhaled product design and development firm Vectura Group PLC said on Thursday based on its trading performance for the year-to-date revenue is currently in line with is a

Read more
11 May 2018 11:35

Nuformix Appoints Former Ventura Chief Executive To Board

LONDON (Alliance News) - Pharmaceutical company Nuformix PLC said Friday that it has appointed Christopher Blackwell, the former chief executive officer of Vectura Group PLC, as non-executive of a

Read more
10 May 2018 16:16

UK Shareholder Meetings Calendar - Next 7 Days

Friday 11 MayBBA AviationMan GroupRSA Insurance GroupJohn Wood Advanced 14 15 Pacific

Read more
24 Apr 2018 13:16

Sosei Group Confirms It Will Not Make Takeover Offer For Vectura

LONDON (Alliance News) - Japanese biotechnology firm Sosei Group Corp said on Tuesday, noting unspecified press reports, it does not intend to make an offer for Vectura Group PLC.Shares in

Read more
23 Apr 2018 09:55

Vectura Adds Ex-GSK And Sanofi Executive Whitaker To Board From June

LONDON (Alliance News) - Vectura PLC said Monday it has appointed Anne Whitaker as non-executive director of the drug development firm from the start of June.Whitaker served as president of

Read more
20 Apr 2018 09:59

Vectura CFO Andrew Derodra Leaves To Take Up Role At Unilabs

LONDON (Alliance News) - Vectura Group PLC on Friday said that its Chief Financial Officer Andrew Derodra will leave the FTSE 250-listed respiratory medicines maker to take a new role within the a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.